FDA Updates Environmental Assessment Requirements for Makers of Certain Biologics

Drug Industry Daily
A A
The FDA expects manufacturers of genetically engineered products that could be harmful if released into the wild to submit environmental assessments (EAs) along with their biologics applications.

To View This Article:

Login

Subscribe To Drug Industry Daily